This sharp decline is just beginning and it has already disrupted the whole system. It is clear that the United States, despite having power greater than the twenty largest countries of the world, including Russia and China, is not currently able to engage in large conventional wars. Washington thus gave up on attacking Syria when the Russian fleet was deployed along the Mediterranean coast. The Pentagon would then have had to launch its Tomawak missiles from the Red Sea over Saudi Arabia and Jordan. Syria and its non-state allies would have answered with a regional war, plunging the United States into a conflict too big for it. In an article published by the New York Times , President Putin opened fire. He stressed that American exceptionalism is an insult to the equality of humans and can only lead to catastrophy. At the podium of the United Nations, President Obama answered that no other nation, not even Russia, wanted to shoulder the burden of the United States. And if they were the police of the world, it was precisely to ensure equality of humans. This intervention is not reassuring : the United States asserting itself as superior to the rest of the world and considering the equality of humans only as their subjects. But the spell is broken. The President of Brazil, Dilma Rousseff, drew applause by demanding an apology from Washington for its universal espionage , while the President of the Swiss Confederation denounced the U.S. policy of force .
Can Iran Trust the United States?
Clair; Gramsci in the Bronx by JoAnn Wypijewski; Obamas Shock Doctrine by Mike Whitney; Pious Virtuosos of Violence by Chris Floyd; and War Chests by Kristin Kolb. CounterPunch by email for only $35 per year. October 02, 2013 Can Iran Trust the United States? by SHELDON RICHMAN People ask whether the United States can trust Iran. The better question is whether Iran can trust the United States. Since 1979 the U.S. government has prosecuted a covert and proxy war against Iran. The objective has been regime change and installation of a government that will loyally serve U.S. state objectives. This war began after the popular overthrow of the U.S. governments client, Shah Mohammad Reza Pahlavi, whose brutal regime the Eisenhower administration and CIA had preserved by driving Irans popular Prime Minister Mohammad Mossadegh from office in 1953. Had the U.S. government not supported the shah and his secret police, there would have been no 1979 Islamic Revolution or 444-day hostage-taking at the U.S. embassy in Tehran.
United States government shutdown begins as Congress hits dead end
Headquartered in Israel, Teva is the world’s leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva’s branded businesses focus on CNS, oncology, pain, respiratory and women’s health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012. Teva’s Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on management’s current beliefs and expectations and involve a number of known and unknown risks and uncertainties that could cause our future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to develop and commercialize additional pharmaceutical products, including our ability to develop, manufacture, market and sell biopharmaceutical products, competition for our innovative products, especially COPAXONE(R) (including competition from innovative orally-administered alternatives, as well as from potential purported generic equivalents), competition for our generic products (including from other pharmaceutical companies and as a result of increased governmental pricing pressures), competition for our specialty pharmaceutical businesses, our ability to achieve expected results through our specialty, including innovative, R&D efforts, the effectiveness of our patents and other protections for innovative products, decreasing opportunities to obtain U.S. market exclusivity for significant new generic products, our ability to identify, consummate and successfully integrate acquisitions, the effects of increased leverage as a result of recent acquisitions, the extent to which any manufacturing or quality control problems damage our reputation for high quality production and require costly remediation, our potential exposure to product liability claims to the extent not covered by insurance, increased government scrutiny in both the U.S. and Europe of our agreements with brand companies, potential liability for sales of generic products prior to a final resolution of outstanding patent litigation, our exposure to currency fluctuations and restrictions as well as credit risks, the effects of reforms in healthcare regulation and pharmaceutical pricing and reimbursement, any failures to comply with complex Medicare and Medicaid reporting and payment obligations, governmental investigations into sales and marketing practices (particularly for our specialty pharmaceutical products), uncertainties surrounding the legislative and regulatory pathways for the registration and approval of biotechnology based products, adverse effects of political or economical instability, corruption, major hostilities or acts of terrorism on our significant worldwide operations, interruptions in our supply chain or problems with our information technology systems that adversely affect our complex manufacturing processes, any failure to retain key personnel or to attract additional executive and managerial talent, the impact of continuing consolidation of our distributors and customers, variations in patent laws that may adversely affect our ability to manufacture our products in the most efficient manner, potentially significant impairments of intangible assets and goodwill, potential increases in tax liabilities, the termination or expiration of governmental programs or tax benefits, environmental risks and other factors that are discussed in our Annual Report on Form 20-F for the year ended December 31, 2012 and in our other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to update or revise any forward looking statement, whether as a result of new information, future events or otherwise. SOURCE: Teva Pharmaceutical Industries Ltd.
In the last five years, Molly has made its way into popular culture, helped by references to it made by entertainers such as Madonna, Miley Cyrus and Kanye West. The drug’s dangers became more clear after a rash of overdoses and four deaths this summer, including two at a huge annual electronic music festival in New York City. The parties of the late 1980s and early ’90s saw the heyday of ecstasy, but its popularity began to wane a decade ago after a number of deaths and hospitalizations. That’s when Molly made her way onto the scene. Over the last few years, drugs sold under that name have “flooded” the market, said Rusty Payne, a spokesman with the Drug Enforcement Administration. In some states, there has been a 100-fold increase – the combined number of arrests, seizures, emergency room mentions and overdoses – between 2009 and 2012, according to DEA figures. The drug is accessible and marketed to recreational drug users who believe it to be less dangerous than its predecessor, which was often cut with other substances, from Ritalin to LSD. Like ecstasy, Molly is said to give a lengthy, euphoric high with slight hallucinogenic properties. In reality, however, the promised pure MDMA experience “doesn’t exist,” said Payne. ‘SOMETHING COMPLETELY DIFFERENT’ Most of the Molly is one of several synthetic designer drugs that have been flooding the U.S. and European marketplace from chemical labs primarily based in China, Payne said. “A lot of people are missing the boat here,” he said. Molly could be anything …
Teva Announces Launch of Generic Zemplar(R) in the United States
It’s choosing not to, as part of a self-imposed political crisis, the details of which you can and should read about elsewhere in this newspaper’s excellent coverage . Sometimes a bit of distance can lend some perspective. As someone who frequently writes about countries that struggle to overcome endemic poverty, bloody sectarian conflict and devastating natural disasters just in the hopes of forming a legitimate political authority, watching the world’s richest and most powerful country sabotage its own government is just breathtaking. Of course, there are other countries that don’t pay prison guards and border patrol but still tell them to show up to work. They’re called failed states. Here’s another country that asks essential security officials to do their jobs without pay: Libya. Time editor Ishaan Tharoor joked that, if you’re curious about what to do during a government shutdown, ask a Somali. The Libyan political crisis that forced it into that position wasn’t a partisan dispute over health care. It was a civil war that annihilated the state, itself a four-decade dictatorship that had hallowed out civil society so meticulously that Libyans were almost starting from zero. Of course, the United States isn’t a failed state; nowhere close. Its problems are a tiny microcosm of Libya’s or Somalia’s or those of other failed states. And that’s exactly what makes this all so strange. America’s little self-imposed crises are a luxury, a reminder not of any innate Libyan-style brokenness but of the spoiled sense of entitlement with which we abuse our own fabulous wealth. “Constant-shutdown, permanent-emergency governance is so destructive that no other serious country engages in or could tolerate it,” The Atlantic’s James Fallows wrote on Friday . “The United States can afford it only because we are — still — so rich, with so much margin for waste and error.” In other countries, they pull their hair out trying to overcome problems far more severe and intractablethan any the United States faces today.
Drug ‘Molly’ is taking a party toll in the United States
Please Log in to update your video settings ‘Shutdown did not have to happen’ US President Barack Obama blames Republicans for an “ideological crusade and urges lawmakers to keep government running. PT1M36S http://www.smh.com.au/action/externalEmbeddedPlayer?id=d-2ur93 620 349 October 2, 2013 – 8:39AM 10 critical questions about a US government shutdown The United States government began a partial shutdown at midnight (2pm today, AEST) for the first time in 17 years, putting as many as 800,000 federal employees out of work, closing national parks and halting some government services after Congress failed to break a partisan deadlock. No further negotiations were immediately planned, raising concerns among some lawmakers that the shutdown could bleed into a fight economists consider even more consequential: how to raise the nations debt limit to avoid a first-ever default after October 17. You dont get to extract a ransom for doing your job, for doing what youre supposed to be doing anyway or just because theres a law there you dont like”: US President Barack Obama. Photo: AP A partial federal government shutdown could cost the US at least $US300 million ($320 million) a day in lost economic output at the start, according to IHS Inc. Thats a fraction of the countrys $US15.7 trillion economy, and the impact is likely to grow over time as skittish consumers and businesses stay on the sidelines. Obama earlier signed emergency legislation ensuring that wages will continue for service members. He says ongoing operations in Afghanistan and elsewhere will continue and the US will ensure those in harms way have what they need. The threats to our national security have not changed, and we need you to be ready for any contingency, Obama said. The president warned however that many non essential civilian contractors, unlike their colleagues in uniform, wont be paid. Chances of a last-minute deal – seen so often in past fiscal fights – evaporated shortly before midnight as the House stood firm on its call to delay major parts of President Barack Obamas health-care law for a year. Senate Democrats were equally firm in refusing.